The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
End-of-life health care utilization (EOLHCU) in patients with thoracic, head and neck cancers with or without phase I study participation at a single institution.
 
Dominic Min-Tran
No Relationships to Disclose
 
Annika Gustafson
No Relationships to Disclose
 
Keith D. Eaton
Research Funding - Mirati Therapeutics (Inst)
 
Elizabeth Trice Loggers
Research Funding - Epizyme (Inst); Karyopharm Therapeutics (Inst); SpringWorks Therapeutics (Inst)
 
Cristina P. Rodriguez
Consulting or Advisory Role - AstraZeneca (I); Merck (I)
Speakers' Bureau - CUE Biopharma
Research Funding - AstraZeneca/MedImmune (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); Ignyta (Inst); Kura Oncology (Inst); Merck (Inst)
 
Rafael Santana-Davila
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Bayer; Bristol-Myers Squibb; Genentech/Roche; Lilly; PharmaMar
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); BeyondSpring Pharmaceuticals (Inst); Genentech (Inst); Lilly (Inst)